investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Immunophysiological Mechanisms in the Biological Therapy of Cancer

Robert Wiltrout

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
The goal is to evaluate the anti-tumor and immunomodulatory potential of AstraZeneca's proprietary compounds, AZD8055 (mTOR blocker) and AZD2171 (VEGF blocker).

Related projects

Justin Reitsma

Mapping the dynamic assembly of SCF E3 ubiquitin ligases during the cell cycle

All cancers but non-melanoma skin cancer

Paul L Fox

A protein-directed RNA switch that regulates translation

All cancers but non-melanoma skin cancer

Kyung Lee

Development of Inhibitors Targeting Plk1 Polo-Box Domain

All cancers but non-melanoma skin cancer

Carol Thiele

Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma

All cancers but non-melanoma skin cancer

Paul B. Jacobsen

Behavioral Oncology Education & Career Development

All cancers but non-melanoma skin cancer

Gavin J Sherlock

Molecular Characterization of Adaptive Evolution

All cancers but non-melanoma skin cancer

Peter Blumberg

Molecular Mechanism of Action of Phorbol Ester – Rockville

All cancers but non-melanoma skin cancer

William C Hahn

The Dana-Farber Cancer Institute Cancer Target Discovery and Development Center

All cancers but non-melanoma skin cancer

Steven Hou

Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging

All cancers but non-melanoma skin cancer